FUL
H.B. Fuller Company NYSE$59.95
After hrs
$58.35
+0.09%
Mkt Cap $3.3B
52w Low $48.71
56.4% of range
52w High $68.63
50d MA $60.62
200d MA $60.13
P/E (TTM)
21.6x
EV/EBITDA
9.7x
P/B
1.6x
Debt/Equity
1.0x
ROE
7.7%
P/FCF
26.3x
RSI (14)
—
ATR (14)
—
Beta
1.04
50d MA
$60.62
200d MA
$60.13
Avg Volume
568.5K
About
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segm…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | AMC | 0.56 | 0.57 | +1.8% | 56.71 | +2.1% | +0.5% | +4.3% | +4.8% | +8.8% | +10.2% | +10.8% | — |
| Jan 14, 2026 | AMC | 1.24 | 1.28 | +3.2% | 64.72 | -1.4% | -1.9% | -6.5% | -10.5% | -8.1% | -6.3% | +4.3% | — |
| Sep 24, 2025 | AMC | 1.24 | 1.26 | +1.6% | 59.27 | -3.8% | -3.9% | -1.9% | -1.3% | +0.0% | -1.1% | +3.7% | — |
| Jun 25, 2025 | AMC | 1.10 | 1.18 | +7.3% | 55.96 | +8.3% | +10.8% | +10.3% | +7.5% | +10.7% | +12.6% | +6.5% | — |
| Mar 26, 2025 | AMC | 0.49 | 0.54 | +9.4% | 54.32 | +6.0% | +6.1% | +0.8% | +3.3% | +5.3% | +6.8% | +0.5% | — |
| Jan 15, 2025 | AMC | 1.24 | 0.92 | -25.8% | 64.14 | -2.3% | -3.0% | -3.2% | -2.8% | -3.7% | -2.8% | -5.1% | — |
| Sep 25, 2024 | AMC | 1.23 | 1.13 | -8.1% | 80.63 | -5.5% | +0.1% | -0.7% | -1.6% | -2.7% | -3.1% | -7.2% | — |
| Jun 26, 2024 | AMC | 1.03 | 1.12 | +8.7% | 76.30 | +5.0% | +0.1% | +0.9% | +0.1% | +0.4% | -0.1% | +11.7% | — |
| Mar 27, 2024 | AMC | 0.64 | 0.67 | +4.7% | 82.58 | -1.9% | -3.4% | -4.4% | -4.5% | -3.9% | -6.0% | -10.1% | — |
| Jan 17, 2024 | AMC | 1.29 | 1.32 | +2.3% | 76.73 | +3.0% | +1.7% | +0.0% | +1.3% | +1.4% | +0.3% | +0.7% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 | Citigroup | Maintains | Buy → Buy | — | $59.17 | $60.00 | +1.4% | +0.5% | +4.2% | +5.6% | +2.3% | -2.0% |
| Mar 27 | UBS | Maintains | Neutral → Neutral | — | $56.99 | $58.01 | +1.8% | +3.8% | +4.3% | +8.2% | +9.6% | +6.2% |
| Mar 19 | Citigroup | Maintains | Buy → Buy | — | $52.05 | $50.67 | -2.7% | -3.3% | -5.3% | -0.0% | +2.3% | +9.0% |
| Jan 16 | Citigroup | Maintains | Buy → Buy | — | $63.49 | $64.27 | +1.2% | -4.6% | -8.8% | -6.3% | -4.4% | -5.4% |
| Jan 16 | UBS | Maintains | Neutral → Neutral | — | $63.49 | $64.27 | +1.2% | -4.6% | -8.8% | -6.3% | -4.4% | -5.4% |
| Oct 22 | Citigroup | Upgrade | Neutral → Buy | — | $60.29 | $61.40 | +1.8% | -1.1% | +0.4% | +2.0% | -0.3% | -0.6% |
| Sep 26 | Seaport Global | Upgrade | Neutral → Buy | — | $56.97 | $58.62 | +2.9% | +2.1% | +2.6% | +4.1% | +2.9% | +3.8% |
| Sep 26 | Citigroup | Maintains | Neutral → Neutral | — | $56.97 | $58.62 | +2.9% | +2.1% | +2.6% | +4.1% | +2.9% | +3.8% |
| Jun 27 | JP Morgan | Maintains | Underweight → Underweight | — | $61.99 | $62.04 | +0.1% | -0.4% | -3.0% | -0.0% | +1.6% | +0.4% |
| Jun 27 | Baird | Maintains | Outperform → Outperform | — | $61.99 | $62.04 | +0.1% | -0.4% | -3.0% | -0.0% | +1.6% | +0.4% |
Recent Filings
8-K
H.B. Fuller Company -- 8-K Filing
I cannot provide a meaningful analysis based on this summary, as it lacks substantive information about the actual corporate event or transaction that H.B. Fuller (FUL) is disclosing in the 8-K filing.
Apr 17
8-K
Unknown — 8-K Filing
H.B. Fuller's appointment of a new General Counsel signals potential leadership restructuring that could indicate strategic shifts, M&A activity, or governance changes—investors should monitor for related announcements affecting company direction.
Mar 26
Data updated apr 25, 2026 10:22am
· Source: massive.com